Published in Thorax on October 01, 2001
Maintenance Schedules Following Pulmonary Rehabilitation | NCT00925171
Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2007 update. Can Respir J (2007) 4.27
General practitioners with a special clinical interest: a model for improving respiratory disease management. Br J Gen Pract (2002) 1.80
Rehabilitation for patients with chronic obstructive pulmonary disease: meta-analysis of randomized controlled trials. J Gen Intern Med (2003) 1.60
Pulmonary rehabilitation: overwhelming evidence but lost in translation? Physiother Can (2010) 1.14
Are decisions using cost-utility analyses robust to choice of SF-36/SF-12 preference-based algorithm? Health Qual Life Outcomes (2005) 1.09
How should COPD patients exercise during respiratory rehabilitation? Comparison of exercise modalities and intensities to treat skeletal muscle dysfunction. Thorax (2005) 0.96
Economic evaluation of a community-based pulmonary rehabilitation program for chronic obstructive pulmonary disease. Lung (2004) 0.96
COPD exacerbations. 4: Prevention. Thorax (2006) 0.88
The short and long term effects of exercise training in non-cystic fibrosis bronchiectasis--a randomised controlled trial. Respir Res (2014) 0.87
Benefits and costs of home-based pulmonary rehabilitation in chronic obstructive pulmonary disease - a multi-centre randomised controlled equivalence trial. BMC Pulm Med (2013) 0.87
The cost-effectiveness of a structured education pulmonary rehabilitation programme for chronic obstructive pulmonary disease in primary care: the PRINCE cluster randomised trial. BMJ Open (2013) 0.86
Distinguishing adult-onset asthma from COPD: a review and a new approach. Int J Chron Obstruct Pulmon Dis (2014) 0.85
Systemic impairment in relation to disease burden in patients with moderate COPD eligible for a lifestyle program. Findings from the INTERCOM trial. Int J Chron Obstruct Pulmon Dis (2008) 0.84
Outpatient vs. home-based pulmonary rehabilitation in COPD: a randomized controlled trial. Multidiscip Respir Med (2010) 0.84
Pulmonary rehabilitation and COPD: providing patients a good environment for optimizing therapy. Int J Chron Obstruct Pulmon Dis (2013) 0.83
Tele-monitoring reduces exacerbation of COPD in the context of climate change--a randomized controlled trial. Environ Health (2013) 0.83
The effects of pulmonary rehabilitation in patients with non-cystic fibrosis bronchiectasis: protocol for a randomised controlled trial. BMC Pulm Med (2010) 0.82
Optimizing economic outcomes in the management of COPD. Int J Chron Obstruct Pulmon Dis (2008) 0.81
Socioeconomic deprivation and the outcome of pulmonary rehabilitation in England and Wales. Thorax (2017) 0.80
The Cost Effectiveness of Maintenance Schedules Following Pulmonary Rehabilitation in Patients with Chronic Obstructive Pulmonary Disease: An Economic Evaluation Alongside a Randomised Controlled Trial. Appl Health Econ Health Policy (2016) 0.79
Time to adapt exercise training regimens in pulmonary rehabilitation--a review of the literature. Int J Chron Obstruct Pulmon Dis (2014) 0.79
The challenge of obtaining information necessary for multi-criteria decision analysis implementation: the case of physiotherapy services in Canada. Cost Eff Resour Alloc (2013) 0.78
Building consensus for provision of breathlessness rehabilitation for patients with chronic obstructive pulmonary disease and chronic heart failure. Chron Respir Dis (2016) 0.77
Non-invasive ventilation (NIV) as an aid to rehabilitation in acute respiratory disease. BMC Pulm Med (2011) 0.77
Multi-center, randomized, placebo-controlled trial of nocturnal oxygen therapy in chronic obstructive pulmonary disease: a study protocol for the INOX trial. BMC Pulm Med (2017) 0.77
Clinician's Commentary. Physiother Can (2010) 0.75
Simulation-Based Estimates of the Effectiveness and Cost-Effectiveness of Pulmonary Rehabilitation in Patients with Chronic Obstructive Pulmonary Disease in France. PLoS One (2016) 0.75
"Show me the money": a fair criticism of economic studies on inhaled bronchodilators for COPD. BMC Pulm Med (2010) 0.75
Pulmonary Rehabilitation Utilization in Older Adults With Chronic Obstructive Pulmonary Disease, 2003 to 2012. J Cardiopulm Rehabil Prev (2016) 0.75
Is a large scale community programme as effective as a community rehabilitation programme delivered in the setting of a clinical trial? BMC Med Res Methodol (2013) 0.75
Use of programme budgeting and marginal analysis as a framework for resource reallocation in respiratory care in North Wales, UK. J Public Health (Oxf) (2015) 0.75
COPD in primary care. Br J Gen Pract (2012) 0.75
Impact of small study bias on cost-effectiveness acceptability curves and value of information analyses. Eur J Health Econ (2014) 0.75
The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care (1992) 144.02
A measure of quality of life for clinical trials in chronic lung disease. Thorax (1987) 10.87
Costs, effects and C/E-ratios alongside a clinical trial. Health Econ (1995) 6.63
Randomised controlled trial of respiratory rehabilitation. Lancet (1994) 4.74
Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease. Lancet (1996) 4.65
Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation. Health Econ (1997) 4.43
Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial. Lancet (2000) 3.68
Deriving a preference-based single index from the UK SF-36 Health Survey. J Clin Epidemiol (1998) 3.57
The CE plane: a graphic representation of cost-effectiveness. Med Decis Making (1990) 2.93
Effects of pulmonary rehabilitation on physiologic and psychosocial outcomes in patients with chronic obstructive pulmonary disease. Ann Intern Med (1995) 2.64
Comparison of outcome measures for patients with chronic obstructive pulmonary disease (COPD) in an outpatient setting. Thorax (1997) 2.32
Long-term effects of outpatient rehabilitation of COPD: A randomized trial. Chest (2000) 1.91
Evaluation of the short-form 36-item questionnaire to measure health-related quality of life in patients with COPD. Chest (1995) 1.90
'Quick and clean': authoritative health technology assessment for local health care contracting. Health Trends (1995) 1.89
A short outpatient pulmonary rehabilitation programme: immediate and longer-term effects on exercise performance and quality of life. Respir Med (1998) 1.62
The effects of a community-based pulmonary rehabilitation programme on exercise tolerance and quality of life: a randomized controlled trial. Eur Respir J (1997) 1.47
Long-term effectiveness of pulmonary rehabilitation in patients with chronic airway obstruction. Eur Respir J (1999) 1.17
Out-patient rehabilitation improves activities of daily living, quality of life and exercise tolerance in chronic obstructive pulmonary disease. Eur Respir J (1997) 1.17
The cost-effectiveness of treating mild-to-moderate hypertension: a reappraisal. J Hypertens (1991) 1.05
Disease management of COPD with pulmonary rehabilitation. Chest (1997) 0.98
Outpatient pulmonary rehabilitation in severe chronic obstructive pulmonary disease. J R Coll Physicians Lond (1998) 0.90
Economic analysis of respiratory rehabilitation. Chest (1997) 0.89
The cost/benefits of outpatient-based pulmonary rehabilitation. Arch Phys Med Rehabil (1997) 0.85
The economic implications of implementing evidence-based diabetic treatment strategies. Int J Clin Pract (1998) 0.81
The Barthel ADL Index: a reliability study. Int Disabil Stud (1988) 9.20
Parental monitoring: association with adolescents' risk behaviors. Pediatrics (2001) 4.15
Influence of platelet size on outcome after myocardial infarction. Lancet (1991) 4.12
A randomized controlled trial of acetyl salicylic acid in the secondary prevention of mortality from myocardial infarction. Br Med J (1974) 3.80
Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial. Lancet (2000) 3.68
Suicide within 12 months of contact with mental health services: national clinical survey. BMJ (1999) 3.61
Using telemedicine for termination of pregnancy with mifepristone and misoprostol in settings where there is no access to safe services. BJOG (2008) 3.40
Peak expiratory flow rates before and after exercise in schoolchildren. Arch Dis Child (1974) 2.93
Audit of a tuberculosis contact tracing clinic. BMJ (1992) 2.80
Mortality in vegetarians and nonvegetarians: detailed findings from a collaborative analysis of 5 prospective studies. Am J Clin Nutr (1999) 2.78
Retracted Enterocolitis in children with developmental disorders. Am J Gastroenterol (2000) 2.70
A novel putative low-affinity insulin-like growth factor-binding protein, LIBC (lost in inflammatory breast cancer), and RhoC GTPase correlate with the inflammatory breast cancer phenotype. Clin Cancer Res (1999) 2.69
Use of free-access minerals. Vet Rec (1992) 2.65
Dietary habits and mortality in 11,000 vegetarians and health conscious people: results of a 17 year follow up. BMJ (1996) 2.61
Detecting and reducing hospital adverse events: outcomes of the Wimmera clinical risk management program. Med J Aust (2001) 2.61
A prospective study of psychological distress and sexual risk behavior among black adolescent females. Pediatrics (2001) 2.48
Helicobacter pylori infection rates in relation to age and social class in a population of Welsh men. Gut (1991) 2.45
What is the optimum duration of anticoagulation for the management of patients with idiopathic deep venous thrombosis and pulmonary embolism? J R Coll Physicians Edinb (2010) 2.36
Lymph node tuberculosis: a comparison of various methods of treatment. Tubercle (1977) 2.35
A community survey of asthmatic characteristics. Thorax (1975) 2.33
Nitrogen cycling and community structure of proteobacterial beta-subgroup ammonia-oxidizing bacteria within polluted marine fish farm sediments. Appl Environ Microbiol (1999) 2.25
Effects of anti-mite measures on children with mite-sensitive asthma: a controlled trial. Thorax (1980) 2.20
Indoor moulds and asthma. J R Soc Health (1988) 2.19
Failure of regional blockade for caesarean section. Int J Obstet Anesth (2002) 2.17
A high-dose preparation of lactobacilli and bifidobacteria in the prevention of antibiotic-associated and Clostridium difficile diarrhoea in older people admitted to hospital: a multicentre, randomised, double-blind, placebo-controlled, parallel arm trial (PLACIDE). Health Technol Assess (2013) 2.09
Long-term mortality after first psychiatric admission. Br J Psychiatry (1997) 2.06
Depression, suicide, and the national service framework. BMJ (2001) 2.02
Wheezing, dampness, and coal fires. Community Med (1981) 2.02
Family size and paternal unemployment in relation to myocardial infarction. J Epidemiol Community Health (1980) 1.93
The effects of discontinuing long-term diuretic therapy in the elderly. Age Ageing (1977) 1.90
Diagnostic role of upper gastrointestinal endoscopy in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr (2004) 1.86
Flexible induction dose regimen for warfarin and prediction of maintenance dose. Br Med J (Clin Res Ed) (1984) 1.83
Elastic scattering spectroscopy accurately detects high grade dysplasia and cancer in Barrett's oesophagus. Gut (2006) 1.78
Ethnic differences in satisfaction with mental health services among representative people with psychosis in south London: PRiSM study 4. Br J Psychiatry (1997) 1.78
Survey of pulmonary tuberculosis in south and west Wales (1976-8). Br Med J (Clin Res Ed) (1982) 1.78
Anticoagulants in venous thromboembolism. BMJ (1988) 1.77
Diagnosing asthma by questionnaire in epidemiological surveys. Clin Exp Allergy (1992) 1.73
Mental disorder and clinical care in people convicted of homicide: national clinical survey. BMJ (1999) 1.71
Purification and properties of L(+)-lactate dehydrogenase from potato tubers. Biochem J (1972) 1.70
Trans-isolate medium: a new medium for primary culturing and transport of Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae. J Clin Microbiol (1984) 1.70
Photodamage to human RPE cells by A2-E, a retinoid component of lipofuscin. Invest Ophthalmol Vis Sci (2000) 1.64
Identification and characterization of a two-component sensor-kinase and response-regulator system (DcuS-DcuR) controlling gene expression in response to C4-dicarboxylates in Escherichia coli. J Bacteriol (1999) 1.64
Dyspnoea and quality of life in older people at home. Age Ageing (2001) 1.64
Bioterrorism preparedness and response: use of information technologies and decision support systems. Evid Rep Technol Assess (Summ) (2002) 1.61
Oxygen as a driving gas for nebulisers: safe or dangerous? Br Med J (Clin Res Ed) (1984) 1.60
Asthma in the elderly: an epidemiological survey. Br Med J (1979) 1.59
Cognitive-behavioral group therapy versus phenelzine in social phobia: long-term outcome. Depress Anxiety (1999) 1.59
Vegetarianism, dietary fiber, and mortality. Am J Clin Nutr (1982) 1.59
Reminiscence therapy for dementia. Cochrane Database Syst Rev (2005) 1.57
Koch's or Crohn's--or something else? Int J Clin Pract (1997) 1.54
Tools for monitoring the effectiveness of district maternity referral systems. Health Policy Plan (2001) 1.54
Management of spontaneous pneumothorax-a Welsh survey. Postgrad Med J (2000) 1.53
Single night studies in obstructive sleep apnea. Sleep (1991) 1.52
Interaction between isoprenaline and aminophylline in asthma. Thorax (1977) 1.52
Eradication of carriage of Neisseria meningitidis in families: a study in Brazil. J Infect Dis (1974) 1.51
Pulmonary infection with mycobacterium xenopi: review of treatment and response. Thorax (1984) 1.50
Accuracy of hepatocellular carcinoma detection on multidetector CT in a transplant liver population with explant liver correlation. Clin Radiol (2011) 1.50
Genetic alterations in 'normal' luminal and myoepithelial cells of the breast. J Pathol (1999) 1.50
Comparison of liver transplantation outcomes from adult split liver and circulatory death donors. Br J Surg (2012) 1.49
Exuberant expression of chemokine genes by adult human articular chondrocytes in response to IL-1beta. Osteoarthritis Cartilage (2008) 1.49
Twice daily slow-release theophylline vs placebo for 'morning-dipping' in asthma. Br J Clin Pharmacol (1984) 1.48
Fatal acute fulminant liver failure due to clozapine: a case report and review of clozapine-induced hepatotoxicity. Gastroenterology (1997) 1.44
Analysis of rewarming curves in Raynaud's phenomenon of various aetiologies. J Hand Surg Eur Vol (2009) 1.43
Anthropometric norms in the elderly. Br J Nutr (1984) 1.42
Lymph node tuberculosis: a comparison of treatments 18 months after completion of chemotherapy. Tubercle (1979) 1.40
Congenital joint laxity and dwarfism in calves. Vet Rec (2000) 1.40
"Opportunist" mycobacterial infections. Thorax (2000) 1.39
Effects of oral zinc supplementation on serum, hair and sweat zinc levels in 7 subjects. Sci Total Environ (1985) 1.38
Video-assisted structured teaching to improve aseptic technique during neuraxial block. Br J Anaesth (2013) 1.38
Treatment of pulmonary infections caused by mycobacteria of the Mycobacterium avium-intracellulare complex. Thorax (1981) 1.35
Correct condom application among African-American adolescent females: the relationship to perceived self-efficacy and the association to confirmed STDs. J Adolesc Health (2001) 1.34
An immunomagnetic separation method using superparamagnetic (MACS) beads for large-scale purification of human mammary luminal and myoepithelial cells. Epithelial Cell Biol (1994) 1.34
SPRED1 mutations (Legius syndrome): another clinically useful genotype for dissecting the neurofibromatosis type 1 phenotype. J Med Genet (2009) 1.32
Pulmonary infection with Mycobacterium kansasii in Wales, 1970-9: review of treatment and response. Thorax (1983) 1.32
Impact of dermoscopy and short-term sequential digital dermoscopy imaging for the management of pigmented lesions in primary care: a sequential intervention trial. Br J Dermatol (2009) 1.32
Collaboration and partnerships: developing the evidence base. Health Soc Care Community (2001) 1.29
In vitro secondary MLR. I. Kinetics of proliferation and specificity of in vitro primed responder cells. J Immunol (1977) 1.29
Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation. Bone Marrow Transplant (2012) 1.28
House dust mite control measures for asthma. Cochrane Database Syst Rev (2004) 1.28
Preparation of the mammalian organ of Corti for scanning electron microscopy. J Microsc (1987) 1.27
Peutz-Jeghers disease: most, but not all, families are compatible with linkage to 19p13.3. J Med Genet (1998) 1.27
Impaired functional capacity is associated with all-cause mortality after major elective intra-abdominal surgery. Br J Anaesth (2010) 1.25
Plasma cholesterol and blood pressure in vegetarians. J Hum Nutr (1981) 1.23
Does infant feeding affect the risk of allergy? Arch Dis Child (1983) 1.22
Donor DNA in a renal cell carcinoma metastasis from a bone marrow transplant recipient. Bone Marrow Transplant (2004) 1.21
Comparison of peak flow gauge and peak flow meter. Thorax (1975) 1.21
Phenelzine vs atenolol in social phobia. A placebo-controlled comparison. Arch Gen Psychiatry (1992) 1.19
Buying 'legal' recreational drugs does not mean that you are not breaking the law. QJM (2010) 1.19
Monitoring effects of oral anticoagulants during treatment with heparin. Br Med J (Clin Res Ed) (1984) 1.18
Anti-mite measurements in mite-sensitive adult asthma. A controlled trial. Lancet (1976) 1.17
Effectiveness of preoperative staging in rectal cancer: digital rectal examination, endoluminal ultrasound or magnetic resonance imaging? Br J Cancer (2004) 1.17
Management of sickle cell disease. Postgrad Med J (1987) 1.17
Narrowing the gap between academic professional wisdom and community lay knowledge: perceptions from partnerships. Public Health (2002) 1.16
Germline mutations of the LKB1 (STK11) gene in Peutz-Jeghers patients. J Med Genet (1999) 1.16